CDIO

What one share of Cardio Diagnostics Holdings holds

In Vitro and In Vivo Diagnostic Substances

Medicine for all. We believe that incorporating Cardio’s solutions into routine practice in primary care and prevention efforts can help alter the trajectory that nearly one in two Americans is expected to develop some form of cardiovascular disease by 2035.

Cardio Diagnostics Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.01
Profit−$2.76
Capex (buildings and equipment)$0.07
Free cash flow−$2.49
Cash and investments$0.00
Book value$2.51

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2021$0.02−$16.00———$26.00
2022$0.01−$45.29————
2023$0.04−$19.81$1.36−$14.78—$4.32
2024$0.04−$9.35$0.24−$5.81—$6.24
2025$0.01−$3.71$0.11−$3.38—$3.82

Common questions about Cardio Diagnostics Holdings

How much does one share of Cardio Diagnostics Holdings earn?

Over the last 12 months, Cardio Diagnostics Holdings lost $2.76 for each share on $0.01 of sales.

Does Cardio Diagnostics Holdings pay a dividend?

Cardio Diagnostics Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Cardio Diagnostics Holdings’s book value per share?

Cardio Diagnostics Holdings’s book value is $2.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Cardio Diagnostics Holdings have?

Each share of Cardio Diagnostics Holdings has $0.00 of cash and investments, as of June 30, 2026.

What is Cardio Diagnostics Holdings’s free cash flow per share?

−$2.49 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Cardio Diagnostics Holdings bought back shares?

Cardio Diagnostics Holdings’s share count rose about 4417% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.